Vlada Frankenberger, DO
Pain Medicine · East Setauket, NYNPI 1528217791
Payments from drug & device makers
Across 71 payments — averaging $49.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abbott$826
- Avanos Medical$294
- Johnson & Johnson$219
- Relievant Medsystems, Inc.$201
- Nalu Medical, Inc.$148
- plus $601 from 11 others
What the payments were for
- Consulting fees$60%
- Food & beverage$3,502100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $1,219 |
| Abbott | 13 | $826 |
| Avanos Medical | 6 | $294 |
| Johnson & Johnson | 5 | $219 |
| Relievant Medsystems, Inc. | 2 | $201 |
| Nalu Medical, Inc. | 2 | $148 |
| AbbVie(2 entities) | 8 | $140 |
| Si-bone, Inc. | 2 | $131 |
| Acelrx Pharmaceuticals, Inc. | 1 | $77 |
| Amgen | 6 | $76 |
| Ferring Pharmaceuticals Inc. | 3 | $62 |
| Medtronic | 1 | $28 |
| IBSA Pharma Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Nevro Corp. | 1 | $19 |
| Pfizer | 1 | $12 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,508 in reported general payments places this provider in the 65th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 254 | $7,939 |
| Diclofenac Sodium | 101 | $4,501 |
| Gabapentin | 279 | $1,838 |
| Methocarbamol | 113 | $916 |
| Tizanidine Hcl | 158 | $615 |
| Oxycodone Hcl | 49 | $501 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $114 |
| Tramadol Hcl | 15 | $18 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in East Setauket
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$627K
- William CaldwellStony Brook$550K
- Brian DurkinPort Jefferson$459K
- Grace FordeNew Hyde Park$398K
- David SpinnerNew York$391K
- John MarkmanRochester$300K
- Naum ShaparinBronx$178K
- Ashraf HenryAmherst$168K
- Kenneth ChapmanStaten Island$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.